title: [Radiotherapy of invasive breast cancer: French national guidelines].
abstract: The French National Cancer Institute (INCa) and Société française de sénologie et pathologie mammaire (SFSPM), in collaboration with a multidisciplinary experts group, have published the French national clinical practice guidelines on a selection of 11 currently debated questions regarding the management of invasive breast cancer. Those guidelines are based on a comprehensive analysis of the current published evidence dealing with those issues, secondly reviewed by 100 reviewers. Radiotherapy was concerned by five of the 11 questions: indications for the boost after whole gland irradiation; hypofractionated radiotherapy; partial breast irradiation; indications for mammary internal nodes irradiation, and indications of radiotherapy after neo-adjuvant chemotherapy.
authors.affiliation: Département recommandations et bon usage du médicament, direction des recommandations et de la qualité de l'expertise, Institut national du cancer, Boulogne-Billancourt, France. sbesnard@institutcancer.fr
authors.forename: S
authors.initials: S
authors.lastname: Besnard
authors.forename: B
authors.initials: B
authors.lastname: Cutuli
authors.forename: A
authors.initials: A
authors.lastname: Fourquet
authors.forename: S
authors.initials: S
authors.lastname: Giard
authors.forename: C
authors.initials: C
authors.lastname: Hennequin
authors.forename: M
authors.initials: M
authors.lastname: Leblanc-Onfroy
authors.forename: V
authors.initials: V
authors.lastname: Mazeau-Woynar
authors.forename: L
authors.initials: L
authors.lastname: Verdoni
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D019583:Dose Fractionation, Radiation; D005260:Female; D005355:Fibrosis; D005602:France; D006801:Humans; D008198:Lymph Nodes / Q000528:radiation effects; D008408:Mastectomy; D015412:Mastectomy, Segmental; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D058958:Organs at Risk; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents